this pos should be $25 based on it's competitors. for some reason WS thinks they are better..yet they don't earn the money of their competitors. laid off 36 people but business is growing? hmmm....8am call...think this will be telling...we go lower tomorrow..just a question of how much...
i am curious about one thing. The numbers were roughly in line with the analyst projections. Are you surprised? The projections themselves were absurd on a valuation basis. But the stock price is being moved by a very small percentage of the outstanding shares because all but a small percentage is owned by institutions. they will try to unload strategically. By forcing management to sell out to a greater fool. Just as Epocrates did. You just have to look down the food chain to someone who wants to get in on the multi trillion dollar market and de-Balkanize it. Jim Clark raised a Billion dollars for a company called Healtheon that got one $25 million dollar contract and then merged withe WebMD and NEIC/Envoy and Medical Manager. And Allscripts and Misys are similar merger monstrosities.
There are very few real companies in this field. Cerner is one. Epic is another. Greenway could be another. On the bottom end eClinical is another.
GE bought IDX and Milbrook and they are finding that running a PMS/EHR company is different from building turbines and lending money. Who would have thought so? It is dying. Which does not make the software bad.
Epic is not public. Eclinical is not public. Being public in this field is not an advantage. Shockingly you cannot run one of these companies well aiming at earnings conference calls every three months. Who would a thunk it?
The reason most of these companies go public is so that the founders can get out. In the world of stocks going public is called the EXIT strategy. The founders get out and the patsies get in. If you are lucky or smart you can make money trading it up or trading it down.
Greenway went public but management kept a huge percentage of their stock.
But back to the subject. Athena numbers are largely in line with analysts projections. The disappointment with the numbers must be because the retail public does not believe the projections are they dont read them.
This is not a bad company. It is a terrible stock.